Overview

Medication, Weight Gain and GI Hormones

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This is an 8 week study that compares two medications. One medication is olanzapine (5-20 mg daily) whereas the other medication is an orally disintegrating medication. Both medications are used to treat depressed bipolar patients. The main focus of this study is the comparison of these two medications on gastro-intestinal hormones and weight gain.
Phase:
Phase 4
Details
Lead Sponsor:
Vanderbilt University
Vanderbilt University Medical Center
Collaborator:
Eli Lilly and Company
Treatments:
Hormones
Olanzapine